Evidence Mapping of the Treatments for Breast Cancer–related Lymphedema

Women treated for breast cancer are facing a lifetime risk of developing lymphedema, which occurs in up to 40% of this population. There is a lack of evidence and limited knowledge regarding the treatment of breast cancer–related lymphedema (BCRL). The aim of this study was to identify, describe, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Sakkaf, Ali M., Masia, Jaume, Auladell-Rispau, Ariadna, Shamardal, Aliaa I., Vasconcello-Castillo, Luis, Sola, Ivan, Bonfill, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Breast
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769095/
https://www.ncbi.nlm.nih.gov/pubmed/35070599
http://dx.doi.org/10.1097/GOX.0000000000004045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769095/
https://www.ncbi.nlm.nih.gov/pubmed/35070599
http://dx.doi.org/10.1097/GOX.0000000000004045

Ejemplares similares